Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study.

Acta oncologica (Stockholm, Sweden) - 1 Mar 2020

Mezheyeuski Artur, Ponten Fredrik, Edqvist Per-Henrik, Sundström Magnus, Thunberg Ulf, Qvortrup Camilla, Pfeiffer Per, Sorbye Halfdan, Glimelius Bengt, Dragomir Anca

Abstract excerpt

Background: Survival and response to therapy in patients with metastatic colorectal cancer (mCRC) are very heterogeneous. There is an unmet need for better markers of prognosis and treatment benefit for mCRC patients. The homeobox 2 gene SATB2 has a highly specific expression in colorectal tissue and is associated with better prognosis in non-metastatic CRC.Material and methods: A population-based cohort of 798...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunochemistry

Share to Matrix Attachment Region Binding Proteins

Share to Neoplasm Metastasis

Share to Proto-Oncogene Proteins p21(ras)

Share to raf Kinases

Share to Scandinavian and Nordic Countries

Source

Identifiers

PMID: 31769323
DOI: 10.1080/0284186X.2019.1691258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study.PMID 31769323Read ↗

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal CarcinomasSemantic proximity Read ↗

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsSemantic proximity Read ↗

Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.Semantic proximity Read ↗

Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinomaSemantic proximity Read ↗

Loss of special <scp>AT</scp>‐rich sequence‐binding protein 1 (<scp>SATB</scp>1) predicts poor survival in patients with colorectal cancerSemantic proximity Read ↗

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.Semantic proximity Read ↗

Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic PitfallSemantic proximity Read ↗

SATB2 is a novel biomarker and therapeutic target for cancerSemantic proximity Read ↗

Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer.Semantic proximity Read ↗

Differential Diagnostic Value of SATB2 in Primary Pulmonary Enteric Adenocarcinoma and Pulmonary Metastases of Colorectal CarcinomaSemantic proximity Read ↗

SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.Semantic proximity Read ↗

SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.